Pharmacokinetic Modeling of Plasma and Intracellular Concentrations of Raltegravir in Healthy Volunteers

Evaluation of the Mean Corpuscular Volume of Peripheral Blood Mononuclear Cells of HIV Patients by a Coulter Counter To Determine Intracellular Drug Concentrations

(2011) Marco Simiele et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Simultaneous determination of raltegravir and raltegravir glucuronide in human plasma by liquid chromatography-tandem mass spectrometric method

(2011) Ling-Zhi Wang et al.   JOURNAL OF MASS SPECTROMETRY

Plasma and Intracellular (Peripheral Blood Mononuclear Cells) Pharmacokinetics of Once-Daily Raltegravir (800 Milligrams) in HIV-Infected Patients

(2010) José Moltó et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients

(2010) Rob Ter Heine et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studies

(2010) David M Burger   Expert Opinion on Drug Metabolism & Toxicology

Effects of Omeprazole on Plasma Levels of Raltegravir

(2009) Marian Iwamoto et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetics of Raltegravir in Individuals With UGT1A1 Polymorphisms

(2009) LA Wenning et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Raltegravir

(2009) Jamie D Croxtall et al.   DRUGS

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

(2009) Jeffrey L Lennox et al.   LANCET

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

(2008) Roy T. Steigbigel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo Correlation

(2007) Marian Iwamoto et al.   JOURNAL OF CLINICAL PHARMACOLOGY